Needham & Company has Upbeat Travels with Medidata Solutions (MDSO); Shares Still 'Underappreciated'
Tweet Send to a Friend
Needham & Company raised its price target on Buy-rated Medidata Solutions (NASDAQ: MDSO) from $49 to $55 following travel with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
